Medicines for Europe Director General Adrian van de Hoven participated in the Open Public Hearing (OPH) of the July 13, 2017 Oncologic Drugs Advisory Committee US FDA Advisory Committee involving biosimilar medicines on 13 July 2017.

Share this
Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedInPin on PinterestBuffer this pageEmail this to someone